Steven Cohen Guardant Health, Inc. Transaction History

Point72 Asset Management, L.P.

$44.6 Billion
Q2 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 56,300 shares of GH stock, worth $3.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

56,300

Previous 776,570 92.75%

Holding current value

$3.74 Million

Previous $33.1 Million 91.15%

% of portfolio

0.01%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$37.05 - $52.04 $26.7 Million - $37.5 Million	-720,270 Reduced 92.75%	56,300 $2.93 Million
Q1 2025 May 15, 2025	SELL	$31.77 - $49.94 $3.07 Million - $4.82 Million	-96,512 Reduced 11.05%	776,570 $33.1 Million
Q4 2024 Feb 14, 2025	BUY	$20.2 - $38.11 $17.6 Million - $33.3 Million	873,082 New	873,082 $26.7 Million
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $6.24 Million - $12.4 Million	388,603 Added 27.24%	1,815,053 $52.4 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $24.4 Million - $38.4 Million	1,426,450 New	1,426,450 $29.4 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $68.5 Million - $106 Million	-2,653,406 Reduced 97.76%	60,879 $1.8 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $56.8 Million - $103 Million	2,714,285 New	2,714,285 $97.2 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $7.81 Million - $10.9 Million	178,942 New	178,942 $9.63 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $3.96 Million - $8.25 Million	-82,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $7.28 Million - $9.89 Million	82,100 New	82,100 $8.21 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $9.24 Million - $12.4 Million	-93,596 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $10.3 Million - $15.5 Million	93,596 New	93,596 $11.6 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $4.62 Million - $6.51 Million	-36,360 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $15.5 Million - $21 Million	-154,856 Reduced 80.98%	36,360 $4.69 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $15.4 Million - $21.4 Million	191,216 New	191,216 $21.4 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $5.59 Million - $8.41 Million	-94,646 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $39.9 Million - $55.5 Million	-670,377 Reduced 87.63%	94,646 $7.4 Million
Q3 2019 Nov 15, 2019	BUY	$62.59 - $110.3 $47.5 Million - $83.8 Million	759,442 Added 13607.63%	765,023 $48.8 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $58,121 - $82,818	909 Added 19.46%	5,581 $482,000
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $160,249 - $457,762	4,672 New	4,672 $358,000

Others Institutions Holding GH

# of Institutions

416

Shares Held

127M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $6.8B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account